MedTrace Logo

Clinical Features of Severe Patients With COVID-19

NCT04450017 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-05-20

No results posted yet for this study

Summary

As coronavirus disease 2019 (COVID-19) spreads across the world, the intensive care unit (ICU) community must prepare for the challenges associated with this pandemic. Providing an efficient care to the patients of the most severely affected category - intensive care unit (ICU) patients - has become one of the serious problems appearing in the COVID-19 pandemics. A typical patient's clinical portrait in ICU of COVID centers is very similar in different countries, however, the key to improve the treatment results for critically ill patients has not yet been found. Data on predictors of severe course in COVID-19 is limited. Knowledge of predictors of severe course of disease can lead to different selection of therapeutic strategy, determine the group of risk of patients for severe course of disease, and improve outcomes.

Conditions

  • SARS-CoV2

Interventions

DIAGNOSTIC_TEST

The demographic, clinical, laboratory, and instrumental data

Measurement of the demographic, clinical data, laboratory data, and instrumental data

Sponsors & Collaborators

  • Federal Research Clinical Center of Federal Medical & Biological Agency, Russia

    lead OTHER_GOV

Principal Investigators

  • Tatiana V Klypa, Dr.Med.Sc. · Federal Research Clinical Center of Federal Medical & Biological Agency

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-06
Primary Completion
2020-06-30
Completion
2020-06-30

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04450017 on ClinicalTrials.gov